Bennett; Stuart Norman Lile
Patent Applications and Registrations
Patent applications and USPTO patent grants for Bennett; Stuart Norman Lile.The latest application filed is for "adamantyl iminocarbonyl-substituted pyrimidines as inhibitors of 11-beta-hsd1 826".
- Bennett; Stuart Norman Lile - Macclesfield GB
- Bennett; Stuart Norman Lile - Cheshire GB
| Patent | Date |
|---|---|
| Therapeutic agents Grant 8,143,263 - Bennett , et al. March 27, 2 | 2012-03-27 |
| Therapeutic agents Grant 8,071,608 - Bennett , et al. December 6, 2 | 2011-12-06 |
| Adamantyl Iminocarbonyl-Substituted Pyrimidines As Inhibitors Of 11-Beta-HSD1 826 App 20110092526 - Bennett; Stuart Norman Lile ; et al. | 2011-04-21 |
| Therapeutic Agents 927 App 20100261733 - Bennett; Stuart Norman Lile ; et al. | 2010-10-14 |
| Compounds For The Inhibition Of Dgat1 Activity App 20100173958 - Bennett; Stuart Norman Lile ; et al. | 2010-07-08 |
| Therapeutic Agents 414 App 20100093757 - BENNETT; Stuart Norman Lile ; et al. | 2010-04-15 |
| Heterocyclic Amide Derivatives Which Possess Glycogen Phosphorylase Inhibitory Activity App 20080064691 - Birch; Alan Martin ; et al. | 2008-03-13 |
| Heterocyclic amide derivatives which process glycogen phorylase inhibitory activity App 20060264494 - Bennett; Stuart Norman Lile ; et al. | 2006-11-23 |
| Indolamid derivatives which possess glycogenphosphorylase inhibitory activity Grant 7,138,415 - Whittamore , et al. November 21, 2 | 2006-11-21 |
| Heterocyclic amide derivatives having glycogen phosphorylase inhibitory activity Grant 7,122,567 - Whittamore , et al. October 17, 2 | 2006-10-17 |
| Indolamide derivatives which possess glycogen phosphorylase inhibitory activity App 20060211760 - Birch; Alan Martin ; et al. | 2006-09-21 |
| Indol-2-amides as glycogen phosphorylase inhibitors App 20060199966 - Bennett; Stuart Norman Lile ; et al. | 2006-09-07 |
| Heterocyclic amide derivatives having glycogen phosphorylase inhibitory activity App 20050131052 - Whittamore, Paul Robert Owen ; et al. | 2005-06-16 |
| Indolamid derivatives which possess glycogenphosphorylase inhibitory activity App 20050107362 - Whittamore, Paul Robert Owen ; et al. | 2005-05-19 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 